Brief: Medivir Medivir Receives Notice Of Allowance In US
20/07/2026 07:35
BRIEF-Medivir Medivir Receives Notice Of Allowance In US July 20 (Reuters) - Medivir AB MEDIVIR.ST:
MEDIVIR: MEDIVIR RECEIVES NOTICE OF ALLOWANCE FOR FOSTROX PLUS LENVATINIB COMBINATION PATENT IN THE USA
FOSTROX PLUS LENVATINIB COMBINATION PATENT PROVIDES PROTECTION AND MARKET EXCLUSIVITY UNTIL AT LEAST APRIL 2041.
THIS ADDS TO PREVIOUS APPROVALS IN EU, JAPAN, AUSTRALIA AND CANADA
NOTICE OF ALLOWANCE INDICATES THAT USPTO INTENDS TO GRANT APPLICATION ONCE STANDARD PROCEDURAL STEPS HAVE BEEN COMPLETED
Source text: ID:nMFN4HrVCf
Further company coverage: MEDIVIR.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))